Fallas CM

Language: Spanish
References: 10
Page: 87-90
PDF size: 441.37 Kb.

ABSTRACT

The ovary syndrome is a heterogeneus disorder of functional androgen excess, detectable either by laboratory analysis or by clinical exam, with ovulatory disfunction and polycystic ovarian morphology. Characterized clinically by oligomenorrhea and hyperandrogenism, as well as the frequent presence of associated risk factors for cardiovascular disease, including obesity, glucose intolerance, and dyslipidemia. Oral contraceptives are the mainstay of pharmacology therapy for women with this syndrome for managing hyperandrogenism and menstrual dysfunction.

REFERENCES

1. Allahbadia G, Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fertility Society Journal (2011) 16, 19-37.

2. Arredondo MI, Rivas AM, Vásquez LA. Diagnóstico y manejo del síndrome de ovario poliquístico: una perspectiva dermatológica. Rev Asoc Colom Dermatl 2010;18:78- 90.

3. Azziz R. Epidemiology and pathogenesis of the polycystic ovary syndrome in adults. UptoDate May 01, 2013.

4. Barbieri R, Ehrmann D. Clinical manifestation of polycystic ovary syndrome in adults. UptoDate June 23, 2014.

5. Barbieri R, Ehrmann D. Diagnosis of polycystic ovary syndrome in adults. UptoDate Sep 2014.

6. Barbieri R, Ehrmann D. Treatment of polycystic ovary syndrome in adults. UptoDate Sep 2014.

7. Casa J, Salmerón A. síndrome de ovario poliquístico en adolescentes. An Pediatr Contin. 2012;10(5):257- 263.

8. Propst A, Wright B. Polycystic Ovarian Syndrome: management options. Obstet Gynecol Clin N Am 2012;39:495-506.

9. Rosenfield R. Diagnostic evaluation of polycystic ovary síndrome in adolescents. UptoDate Sep 2014.

10. Silva R. Síndrome de ovario poliquístico e infertilidad. Rev. Med. Clin. Condes 2010:21:387-396.